Business Context and Reporting Period
Company: ILLUMINA, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2020
Event: Presentation of preliminary financial results for the quarter and year ended December 29, 2019, at the J.P. Morgan Healthcare Conference in San Francisco, California.
Key Financial Metrics
This filing serves as a notice of a presentation and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity. The actual financial figures were presented in a webcast and a transcript (Exhibit 99.1), which are incorporated by reference but not detailed within the text of this 8-K summary.
Material Changes
The filing does not explicitly list material changes versus prior periods. It references a presentation discussing preliminary results for the period ended December 29, 2019, but the specific variances are contained in the attached transcript.
Guidance, Outlook, and Management Commentary
- Guidance: The filing includes Exhibit 99.2, titled "Reconciliation of non-GAAP financial guidance for fiscal year 2020," indicating that forward-looking guidance was provided during the conference presentation.
- Management Commentary: Management discussed preliminary results for the quarter and full year ended December 29, 2019.
- Legal Status: The information in Item 2.02 is "furnished" and not "filed" under the Exchange Act. It shall not be incorporated by reference into registration statements unless expressly stated.
Investor Verification Checklist
- Review the full transcript of the J.P. Morgan Healthcare Conference presentation (Exhibit 99.1) for specific revenue and earnings figures.
- Examine the reconciliation of non-GAAP financial guidance for fiscal year 2020 (Exhibit 99.2) to understand management's forward-looking assumptions.
- Verify the preliminary results for the quarter and year ended December 29, 2019, against the company's official 10-K filing for the full year.
- Note that the data in this 8-K is not legally "filed" for liability purposes under Section 18 of the Exchange Act.